KYORIN Pharmaceutical Market Cap

KYORIN Pharmaceutical has a market cap or net worth of 89.50 billion as of April 28, 2026. Its market cap has increased by 6.93% in one year.

Market Cap

89.50B

Enterprise Value

101.08B

Revenue

133.26B

Ranking

n/a

PE Ratio

8.31

Stock Price

1,558.00

Market Cap Chart

Since March 10, 2006, KYORIN Pharmaceutical's market cap has increased from 18.24B to 89.50B, an increase of 390.57%. That is a compound annual growth rate of 8.21%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	89.50B	1.36%
Dec 30, 2025	88.30B	2.13%
Dec 30, 2024	86.46B	-15.45%
Dec 29, 2023	102.26B	3.75%
Dec 30, 2022	98.56B	-6.82%
Dec 30, 2021	105.78B	-4.89%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Zeria Pharmaceutical	94.43B
ASKA Pharmaceutical Holdings	84.76B
Mochida Pharmaceutical	118.76B
Fuji Pharma	57.15B
Kaken Pharmaceutical	153.56B
Kissei Pharmaceutical	188.81B
Towa Pharmaceutical	201.10B
Daito Pharmaceutical	36.48B

Market Cap Rankings